A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
This study is currently recruiting participants.
Verified July 2017 by Genentech, Inc.
F. Hoffmann-La Roche
Information provided by (Responsible Party):
First received: October 27, 2008
Last updated: July 11, 2017
Last verified: July 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||February 28, 2023|
|Estimated Primary Completion Date:||December 30, 2022 (Final data collection date for primary outcome measure)|